Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 210-852-7 | CAS number: 624-54-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2008
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: The study was conducted according to OECD TG 429, EPA OPPTS 870.2600, EU Method B.42 and in accordance with the Principles of Good Laboratory Practice.
- Reason / purpose for cross-reference:
- reference to same study
- Reason / purpose for cross-reference:
- reference to other study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.2600 (Skin Sensitisation)
- Deviations:
- no
- Principles of method if other than guideline:
- not applicable
- GLP compliance:
- yes
- Type of study:
- mouse local lymph node assay (LLNA)
- Species:
- mouse
- Strain:
- CBA
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Harlan, Indianapolis, Indiana
- Age at study initiation: approximately 9-12 weeks
- Housing: Animals were housed up to six per cage in filter tubs containing corncob bedding.
- Diet (e.g. ad libitum): ad libitum, food pellets (LabDiet Certified Rodent Diet #5002 (PMI Nutrition International, St. Louis, Missouri) were provided
- Water (e.g. ad libitum): water bottle or a crock filled with water
- Acclimation period: at least 1 week prior to study
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22°C with a tolerance of ± 1°C (and a maximum permissible excursion of ± 3°C)
- Humidity (%): 40-70%
- Air changes (per hr): 12-15 times/hour
- Photoperiod (hrs dark / hrs light): 12 hours light/dark cycle - Vehicle:
- acetone/olive oil (4:1 v/v)
- Concentration:
- 5%, 25%, or 100% n-Pentyl Propionate
- No. of animals per dose:
- Six female mice/group
- Details on study design:
- RANGE FINDING TESTS: Prior to the LLNA study, several concentrations of the test material were evaluated for irritation potential as measured by erythema of the ears. Mice (one female/concentration) received one application of n-Pentyl Propionate (1%, 5%, 25%, 50%, 75%, or 100%), on the dorsal surface of each ear (25 μl) on three consecutive days. Using an adjustable pipette with a disposable tip, the test solutions (25 μl/ear) were spread over the dorsal surface of each ear in a manner to prevent material loss. Ears were inspected prior to application of the test material solutions, and erythema was evaluated on days 2, 3, and 6.
All mice were weighed on days 1 and 6. Erythema scores and body weight data following test material applications were compared to the response of the animals treated with vehicle alone. Erythema was absent and body weights were unaffected in all dose groups.
MAIN STUDY: The application of the test material (25 μl/ear) was made on the dorsal surface of both ears. Six female mice/group received one of three concentrations of n-Pentyl Propionate (5%, 25%, or 100%) or vehicle (4:1 AOO) once daily for three consecutive days. HCA at 30% (v/v) in vehicle was run concurrently as a positive dermal sensitization control. Ears were inspected prior to application of the test material solutions, and erythema was evaluated on days 2, 3, and 6. All mice were weighed on days 1 and 6. On day 6, all mice received a 250 μl intravenous injection (i.v.) via the lateral tail vein containing 20 μCi of 3H-thymidine (specific activity 2Ci/mmol; Amersham code TRA310, Buckinghamshire, United Kingdom) diluted in phosphatebuffered saline (PBS). Approximately five hours post administration, the mice were euthanized via CO2 asphyxiation and both auricular lymph nodes located at the bifurcation of the jugular veins were excised and placed in PBS. A single cell suspension of the auricular lymph nodes from one mouse was prepared by gentle mechanical disaggregation using a tissue homogenizer (Stomacher 80 Lab System, Seward Ltd., London, United Kingdom). The cells were washed two times and were suspended in 3 ml of 5% trichloroacetic acid (TCA) for approximately 18 hours. The suspended precipitates were centrifuged (200 x g for 10 minutes) and the supernatant removed. The pellet from each mouse was reconstituted in 1 ml of 5% TCA and subsequently transferred to a scintillation vial containing 10 ml of Aquasol-2 scintillation cocktail (Packard Instrument Company, Meridan, Connecticut). Two additional 2 ml aliquots of water were used to rinse the tubes and the rinses were added to the scintillation vials containing the 1 ml of pellet in TCA and cocktail. The radioactivity in each precipitate was measured using a β-scintillation counter and reported as disintegrations per minute (dpm) per mouse. A mean dpm value ± SD (standard deviation) was calculated for each experimental group. The SI was calculated using the absolute dpm value for each mouse as the numerator and the mean dpm value from the vehicle control mice as the denominator; the mean SI ± SD was calculated for each experimental group. Any test material that produced a SI of > 3 in the LLNA was considered “positive” for contact sensitization. While the criterion for a positive response (SI > 3) was originally developed empirically, a recent robust statistical evaluation indicated that it is an acceptable practical value for hazard identification (Basketter et al., 1999a). Furthermore, by determining EC3 values (estimated concentration resulting in a 3-fold SI), one can compare relative sensitization potency of chemicals and/or formulations (Basketter et al., 1999b). While a test material that produces a SI of > 3 in the LLNA should be considered “positive” for contact sensitization (Kimber et al., 1994), recent opinions have suggested circumstances in which the LLNA result and sensitization potential should be further considered in the context additional, scientific judgment (Ryan
et al., 2000; Basketter et al., 1998; Basketter et al., 2006). Based on the EC3 values derived from the LLNA, it has been proposed that contact allergens can be categorized as weak (≥ 10% - ≤ 100%), moderate (≥ 1% - < 10%), strong (≥ 0.1% - < 1%), or extreme (< 0.1%); (ECETOC, 2003). The EC3 value is determined by interpolating between two values one above and one below the SI value of 3 (Statistics and Calculations)
TREATMENT PREPARATION AND ADMINISTRATION: n-Pentyl Propionate was combined with vehicle (4:1 AOO) to obtain concentrations of 5%, 25%, and 100%. Solutions were prepared daily just prior to dosing. Preparation of the dosing materials was documented in the study file. The concentrations of the dosing solutions were not verified analytically. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Statistics:
- The Stimulation Index (SI) and EC3 values were calculated using appropriate methods. Means and standard deviation (SD) were generated for body weight data (absolute and gain) and the LLNA response (dpm & SI values). These body weight and dpm data were analyzed by a one-way analysis of variance (Steele and Torrie, 1960). When differences were indicated by the ANOVA, a comparison of treated vs. control groups was done using a Dunnett’s t-test (Steele and Torrie, 1960). The alpha level at which all tests were conducted was 0.05.
- Positive control results:
- Proper conduct of the LLNA was demonstrated via the positive response from the positive control, 30% HCA, which elicited a stimulation index (SI) that was 7.4 in comparison to vehicle-treated mice.
- Parameter:
- SI
- Value:
- 1.7
- Test group / Remarks:
- 5%
- Parameter:
- SI
- Value:
- 1.1
- Test group / Remarks:
- 25%
- Parameter:
- SI
- Value:
- 1.8
- Test group / Remarks:
- 100%
- Parameter:
- other: disintegrations per minute (DPM)
- Remarks on result:
- other: Mice treated with 5%, 25% and 100% n-Pentyl Propionate exhibited values (dpm) that were respectively 1759.7, 1096.3 and 1845.5 in comparison to vehicle-treated mice.
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- n-Pentyl Propionate did not demonstrate dermal sensitization potential in the mouse LLNA as the lymph nodes draining the area of topical application did not demonstrate a 3-fold increase in proliferation when compared to vehicle-treated mice.
- Executive summary:
The Local Lymph Node Assay (LLNA) study was conducted according to OECD TG 429, EU method B.49, EPA OPPTS 870.2600 and according to the Principles of Good Laboratory Practice (GLP), to assess the potential of n-Pentyl Propionate to cause contact sensitization by measuring lymphocyte proliferative responses from auricular lymph nodes following topical application of the test material to the mouse ear.
Screening Study: Three daily topical applications of 1%, 5%, 25%, 50%, 75%, or 100% n-Pentyl Propionate were given to one animal at each dose level. Erythema was absent and body weights were unaffected in all dose groups. Results from this study were used to determine the dosing concentrations for n-Pentyl Propionate in the LLNA.
LLNA: Six female mice/group received 5%, 25%, or 100% n-Pentyl Propionate, or vehicle (4:1 Acetone Olive Oil (AOO)) or 30% α-hexylcinnamaldehyde (HCA; positive control) on days 1-3. On day 6, uptake of 3H-thymidine into the auricular lymph nodes draining the site of chemical application was measured five hours post administration. Proper conduct of the LLNA was confirmed via a positive response using 30% α- hexylcinnamaldehyde (HCA), a moderate contact sensitizer, which elicited proliferation that was 7.4 in comparison to vehicle-treated mice.
Erythema was absent and body weights were unaffected in all dose groups.
Mice treated with 5%, 25% and 100% n-Pentyl Propionate exhibited proliferative responses with stimulation indices (SI) that were respectively 1.7, 1.1 and 1.8 in comparison to vehicle treated mice.
Therefore, n-Pentyl Propionate did not demonstrate dermal sensitization potential in the mouse LLNA as the lymph nodes draining the area of topical application did not demonstrate a 3-fold increase in proliferation when compared to vehicle-treated mice.
Reference
None
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
In a GLP study conducted according to OECD TG 429 (LLNA), Pentyl Propionate did not demonstrate dermal sensitization potential in the mouse LLNA as the lymph nodes draining the area of topical application did not demonstrate a 3-fold increase in proliferation when compared to vehicle-treated mice.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
There are no studies available for assessment of respiratory sensitization of pentyl propionate and since skin sensitization was not noted in the GLP study conducted according to OECD TG 429, it is expected that pentyl propionate will not cause respiratory sensitization.
Migrated from Short description of key information:
There are no studies available for assessment of respiratory sensitization of pentyl propionate and since skin sensitization was not noted in the GLP study conducted according to OECD TG 429, it is expected that pentyl propionate will not cause respiratory sensitization.
Justification for classification or non-classification
In a GLP study conducted according to OECD TG 429 (LLNA), Pentyl Propionate did not demonstrate dermal sensitization potential in the mouse LLNA as the lymph nodes draining the area of topical application did not demonstrate a 3-fold increase in proliferation when compared to vehicle-treated mice. There are no studies available for assessment of respiratory sensitization of pentyl propionate and since skin sensitization was not noted in the GLP study conducted according to OECD TG 429, it is expected that pentyl propionate will not cause respiratory sensitization.
On the basis of the available information and based on the Guidance to Regulation (EC) No. 1272/2008 on Classification, Labelling and Packaging of substances and mixtures, pentyl propionate will not be classified for skin and respiratory sensitization.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.